PRLog - Feb. 25, 2014 - NEW YORK -- BrainTracer, LLC, a NYC based mHealth venture, announces the launch of MoodTune, the first mobile platform for people suffering from depression.
Daily mood tracking
MoodTune is an iOS and Android based mobile platform for users who suffer from major depressive disorder (MDD) and related mental health conditions. MDD is a major health concern in the USA and beyond with close to 20 million people suffering from it and as many as twice that much experiencing symptoms. MoodTune provides a platform to support treatment outcomes and manage the condition.
At the core of the platform are interactive tasks using validated neuroscientific findings to target symptom improvement and support treatment outcome for patients affected by MDD. MoodTune users are encouraged to play these tasks for up to 30 minutes a day, every day, to see an improvement in their mood. Additionally, MoodTune provides features to assess, track and review your mood all within the same mobile platform.
The science behind MoodTune comes out of the leading research universities and is currated by BrainTracer's Scientific Advisory Board http://www.braintracercorp.com/#!
"A mobile platform is a revolution in helping and optimizing existing treatments" says André König, CEO and Co-Founder of BrainTracer, "It brings a low-cost, anonymous tool to users who suffer from MDD that they can use in the comfort and privacy of their own home, or on the go.". He adds that "the powerfull backend technology behind MoodTune, allows us to collect HIPAA compliant user and performance data, which enables us to continuously analyze and improve the product."
MoodTune is available in app stores for free (basic version) and currently charges a $9.99 fee for access to the full version, which includes the tasks. https://itunes.apple.com/
For more information, please visit www.braintracercorp.com or contact the company at below email address.